antiviral
| 4 min read
Phase 3 trial results for neurological drugs, an AI platform for central nervous system drug discovery, a novel long-acting flu antiviral, and more led the news this week.
| 4 min read
Two reports landed the same week: one documenting rising pandemic risk, the other showing how little of the antiviral pipeline is ready to meet it. Then Ebola was declared a public health emergency.
| 3 min read
Researchers developed a highly tolerable oral antiviral against orthoparamyxoviruses like measles and human parainfluenza virus types 1 and 3.
| 2 min read
New study uses simulations and machine learning to identify a single, high-impact interaction within a viral fusion protein, highlighting a potential new target for antiviral drug development.
| 4 min read
New vaccines and antiviral injections that could offer significantly better and broader protection against the flu are now in clinical trials.
| 2 min read
Enamine’s chemistry platform delivered over 2,000 novel compounds to accelerate the discovery of pre-clinical candidate ASAP-0017445.
| 4 min read
Vertex-Enlaza autoimmune drugs, DNA-wrapped CRISPR, HHS staff demand Kennedy’s resignation, and more lead the news this week.
| 5 min read
A compound that inhibits replication of the dengue virus in mammals was similarly effective in mosquitoes consuming it via blood, reducing transmissibility.
Page 1 of 1 - 8 Total Items
